At a glance
ClinicalIndex Comparison RecordPhase 4Completed· 60 enrolled
Drug / intervention
Rocuronium +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Comparison of General Anesthesia With Use of Muscle Relaxation and General Anesthesia Without Muscle Relaxation on Recovery of Muscle Strength of the Patients
In Brief
A Phase 4 clinical trial evaluating Rocuronium and General anesthesia for surgery for Rocuronium and 2 related conditions. Completed, enrolled 60 participants across 1 site.
Detailed Summary
Neuromuscular blocking agents are often used during general anesthesia. Also, general anesthesia may be performed without use of neuromuscular blocking agents. Avoiding neuromuscular relaxation enables better muscle strength recovery.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsRocuronium, Muscle Weakness, General Anaesthesia
CountriesCroatia
Collaborators--
Timeline
Phase 4CompletedFinished
202120222023202420252026
Enrollment StartApr 2020
First PostedFeb 2021
Primary CompletionAug 2022
Study CompletionSep 2022
TodayJul 2026
First PostedFeb 18, 2021
Enrollment StartApr 1, 2020
Primary CompletionAug 20, 2022
Study CompletionSep 20, 2022
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 5.4 years ago
Interventions
Rocuroniumdrug
Rocuronium used for neuromuscular blokade during anesthesia and anesthesia without rocuronium
General anesthesia for surgeryprocedure
General anesthesia with standard anesthetic monitoring,